Research and development of 2-ethyl-6-methyl-3-oxypyridine succinate nano-form for the treatment of epilepsy

Research and development of 2-ethyl-6-methyl-3-oxypyridine succinate nano-form for the treatment of epilepsy

The aim is to develop an antiepileptic drug based on polymer nanoparticles with 2-ethyl-6-methyl-3-oxypyridine succinate to facilitate the drug transport through the blood-brain barrier.Materials and methods. The nano-drug was created using the biologically active substance 2-ethyl-6-methyl-3-hydrox...

Full description

Bibliographic Details
Main Authors: G. G. Avakyan, T. A. Voronina, L. N. Nerobkova, G. N. Avakyan
Format: Article
Language:Russian
Published: IRBIS LLC 2019-03-01
Series:Эпилепсия и пароксизмальные состояния
Subjects:
epilepsy
antiepileptic drugs
nano-medicine
nano-technology
nano-preparation
polybutylcyanoacrylate nanoparticles
Online Access:https://www.epilepsia.su/jour/article/view/439

Internet

https://www.epilepsia.su/jour/article/view/439

Similar Items